International Biotechnology Trust PLC Neurocrine Biosciences Inc Transaction History

International Biotechnology Trust PLC

$295 Million
Q3 2023

A detailed history of International Biotechnology Trust PLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, International Biotechnology Trust PLC holds 28,877 shares of NBIX stock, worth $3.72 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares

28,877

Previous 68,877 58.07%

Holding current value

$3.72 Million

Previous $6.5 Million 49.99%

% of portfolio

1.1%

Previous 2.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $3.76 Million - $4.68 Million	-40,000 Reduced 58.07%	28,877 $3.25 Million
Q2 2023 Aug 08, 2023	BUY	$89.53 - $104.87 $6.17 Million - $7.22 Million	68,877 New	68,877 $6.5 Million
Q3 2022 Nov 08, 2022	BUY	$92.03 - $107.81 $643,473 - $753,807	6,992 Added 30.39%	30,000 $3.19 Million
Q2 2022 Aug 16, 2022	SELL	$75.79 - $100.07 $13.6 Million - $18 Million	-179,992 Reduced 88.67%	23,008 $236 Million
Q1 2022 May 20, 2022	SELL	$72.45 - $94.81 $5.58 Million - $7.3 Million	-77,000 Reduced 27.5%	203,000 $19 Million
Q4 2021 Feb 15, 2022	SELL	$79.65 - $106.22 $756,675 - $1.01 Million	-9,500 Reduced 3.28%	280,000 $23.8 Million
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $7.11 Million - $8.17 Million	82,500 Added 39.86%	289,500 $27.7 Million
Q1 2021 May 17, 2021	BUY	$87.57 - $119.4 $16 Million - $21.9 Million	183,000 Added 762.5%	207,000 $20.1 Million
Q4 2020 Feb 19, 2021	SELL	$86.91 - $108.33 $17.2 Million - $21.4 Million	-197,800 Reduced 89.18%	24,000 $2.3 Million
Q3 2020 Dec 01, 2020	BUY	$96.16 - $135.15 $11.2 Million - $15.7 Million	116,000 Added 109.64%	221,800 $21.3 Million
Q2 2020 Jul 14, 2020	SELL	$85.09 - $130.36 $127,635 - $195,540	-1,500 Reduced 1.4%	105,800 $13.3 Million
Q1 2020 May 18, 2020	SELL	$75.11 - $113.76 $1.95 Million - $2.96 Million	-26,000 Reduced 19.5%	107,300 $9.29 Million
Q4 2019 May 18, 2020	SELL	$86.8 - $118.57 $1.22 Million - $1.66 Million	-14,000 Reduced 9.5%	133,300 $14.3 Million
Q3 2019 Nov 14, 2019	SELL	$83.82 - $101.5 $796,289 - $964,250	-9,500 Reduced 6.06%	147,300 $13.3 Million
Q2 2019 Aug 14, 2019	BUY	$72.24 - $91.27 $3.84 Million - $4.86 Million	53,200 Added 51.35%	156,800 $13.2 Million
Q1 2019 May 14, 2019	SELL	$69.31 - $91.53 $1.54 Million - $2.03 Million	-22,200 Reduced 17.65%	103,600 $9.13 Million
Q4 2018 Feb 14, 2019	BUY	$68.32 - $124.36 $6.17 Million - $11.2 Million	90,300 Added 254.37%	125,800 $7.05 Million
Q3 2018 Nov 14, 2018	SELL	$98.88 - $125.85 $1.69 Million - $2.15 Million	-17,046 Reduced 32.44%	35,500 $3.35 Million
Q3 2018 Nov 13, 2018	SELL	$98.88 - $125.85 $11 Million - $14 Million	-110,954 Reduced 67.86%	52,546 $2,000
Q2 2018 Aug 13, 2018	BUY	$75.3 - $105.99 $715,350 - $1.01 Million	9,500 Added 6.17%	163,500 $16.1 Million
Q1 2018 May 15, 2018	BUY	$75.88 - $92.43 $8.88 Million - $10.8 Million	117,000 Added 316.22%	154,000 $12.8 Million
Q4 2017 Mar 02, 2018	SELL	$58.53 - $77.59 $1.7 Million - $2.25 Million	-29,000 Reduced 43.94%	37,000 $2.87 Million
Q3 2017 Mar 02, 2018	BUY	$47.97 - $61.28 $3.17 Million - $4.04 Million	66,000 New	66,000 $4.04 Million
Q2 2017 Mar 02, 2018	SELL	N/A	-40,264 Closed	0 $0
Q4 2016 Mar 02, 2018	BUY	N/A	40,264	40,264 $1.56 Million

Others Institutions Holding NBIX

# of Institutions

652

Shares Held

100M

Call Options Held

700K

Put Options Held

237K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.3B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Account

International Biotechnology Trust PLC Neurocrine Biosciences Inc Transaction History